Illumina, Inc.

Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California, and it serves more than 155 countries. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets.

Illumina, Inc.
Company typePublic
Traded as
  • Nasdaq: ILMN
  • Nasdaq-100 component
  • S&P 500 component
IndustryBiotechnology
Founded1998 (1998)
Founders
Headquarters
San Diego, California
,
U.S.
Key people
  • Jacob Thaysen
  • (CEO)
  • Stephen P. MacMillan (Chairman)
Products
  • NovaSeq
  • HiSeq
  • MiSeq
  • MiniSeq
  • iSeq
  • NextSeq
  • iScan
  • COVIDSeq
  • VeriSeq
  • DRAGEN
  • Illumina Connected Analytics
  • TruSight Oncology
Revenue US$4.50 billion (2023)
US$−1.1 billion (2023)
Net income
 US$−1.2 billion (2023)
Total assets US$10.1 billion (2023)
Total equity US$5.75 billion (2023)
Number of employees
9,250 (2023)
Websiteillumina.com
Footnotes / references

Illumina's customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.